While these biologics are highly effective in treating various autoimmune diseases through inhibition of the proinflammatory signaling predominantly mediated by TNFR1, they concurrently suppress the beneficial immunoregulatory effects via TNFR2. The gene discussed is TNFRSF1B; the disease is autoimmune disease.